Introduction
Borrelia burgdorferi (Bb) , the cause of Lyme disease, has appeared not to evoke a detectable specific antibody response in humans until long after infection. This delayed response has been a biologic puzzle and has hampered early diagnosis. Antibody to the abundant organism-specific outer surface proteins, such as the 31-kD OspA, has rarely been detected less than 6 mo after infection. Antibody to a less organism-specific 41-kD flagellin protein, sharing common determinants with other bacteria and thus limiting its diagnostic potential, may appear after 4 to 6 wks. To investigate our hypothesis that specific antibody to OspA may actually be formed early but remain at low levels or bound in immune complexes, we analyzed serum samples from patients with concurrent erythema migrans (EM). This is the earliest sign of Lyme disease and occurs in 60-70% of patients, generally 4-14 d after infection. We used less conventional but more sensitive methods: biotin-avidin Western blots and immune complex dissociation techniques. Antibody specificity was confirmed with recombinant OspA.
Specific complexed antibody to whole Bb and recombinant OspA was detected in 10 of 11 of the EM patients compared to 0 of 20 endemic area controls. IgM was the predominant isotype to OspA in these EM patients. Free IgM to OspA was found in half the EM cases. IgM to OspA was also detected in 10 of 10 European patients with EM who also had reactive T cells to recombinant OspA.
In conclusion a specific antibody response to OspA occurs early in Lyme disease. This is likely to (1, 2) . Clinical suspicion of the diagnosis has often been difficult to confirm with current serological methods (3). The human humoral response to the relatively abundant and highly specific Bb outer surface proteins such as OspA, is not usually detected until several months to years after infection (4, 5) . Seronegative, and even some seropositive Lyme arthritis patients with a past history of erythema migrans (EM) and more than 6 mo of symptoms do not have demonstrable OspA antibody (Ab) (4) by conventional Western blots (6) or ELISA. This delayed humoral response has been puzzling and has hampered early diagnosis (7) . This is particularly problematic because the early clinical marker for infection, erythema migrans (EM), which occurs on the average 4 to 14 d after an infected tick bite, is not observed in over one-third of cases (3) . Furthermore, in many instances the rash is atypical, and a confident diagnosis of EM cannot be made. Though an Ab response may occur to the 41-kD flagellin protein (8) , it is usually delayed 4 to 6 wks after the infection, and its diagnostic utility is further limited because these antigenic components are commonly shared with other bacteria (4) (5) (6) . Similarly, Ab may be produced to other proteins which are not unique to Bb.
The potential to produce Ab to OspA early is illustrated by certain mouse infectivity models where a brisk response does occur after needle inoculation (9) . We hypothesized that early after infection in humans via a tick bite, Ab to OspA may actually be produced at low levels not detectable by conventional methods and/or be predominantly bound in immune complexes. This follows the general observation that the normal humoral immune response to an infection involves production of Ab which then binds to provoking antigens (Ags) of the infectious agent (10) Immune complex (IC) isolation and dissociation. Immune complexes were isolated by polyethylene glycol precipitation and dissociated as described (11, 12) . Briefly, 0.5 ml of the serum sample was added to an equal volume of 7% polyethylene glycol (PEG) in PBS, and incubated overnight (or alternatively 2 h) at 40C, then centrifuged at 8,320 g for 15 min. Pellets were washed twice using 3.5% PEG and resuspended in 0. Fig. 1 (Table II) . A biotin-avidin IgM IC ELISA was positive in 7 of 7 available EM serum samples. The controls had a mean OD of 0.08 (average ranging from 0.04 to 0.15) and the mean + 3 SD was 0.20. 20 healthy endemic area controls and 20 other diseased patients (infections including syphilis, autoimmune diseases such as lupus, allergic, and neurologic disorders, especially cases associated with elevated levels of immune complexes) were not reactive for either free or complexed Ab to OspA (see Fig. 3 ), whereas certain chronic Lyme disease patients and several anti-OspA mAbs (H3TS and H5332 kindly provided by Dr. Alan Barbour) could recognize OspA (see Fig. 1 and 2) .
The predominant anti-OspA isotype was IgM. In 2 of the 10 early cases of Lyme disease with specific Bb immune complexes, both IgM and IgG isotypes were found in the complexes. In 2 of 10 EM patients, including one with a documented past history of Bb infection and EM, the anti-OspA reactivity was found solely in the complexed IgG fraction. This could reflect an amnestic response. In half of the early (EM) Lyme disease patients with complexed IgM to recombinant OspA, biotin-avidin blots also detected free IgM Ab to the recombinant protein. Analysis of the German EM patients also revealed specific IgM to recombinant OspA in 10 of 10 cases (Fig. 4) .
Discussion
The current studies demonstrate that OspA is recognized by the immune system, and that specific anti-OspA Ab can be produced early in human Bb infection. The predominant isotype in new acute cases was IgM, as might be expected with an early Ab response. In this paper we have equated "early" with the time that EM appeared or is most likely to appear.
Dissociation between T cell and B cell responses to antigenic components of Bb has been described in certain chronic seronegative patients who exhibit T cell reactivity to Bb, but no detectable free Ab to Bb (6) . Recently, in early Lyme disease patients, T cells reactive to OspA have been identified in the absence of free Ab to OspA (14) . However, complexed Ab was not investigated in these studies, nor were blots performed with biotin-avidin reagents. We point this out because both these techniques are likely to enhance the sensitivity of detection. We In humans, the ability to detect Ab to OspA in the early weeks resolves part of a biologic puzzle. Detection of specific Ab has important potential to support a clinical diagnosis in this illness, especially at the outset, when therapy is most likely to be effective, and can be a diagnostic aid in patients who were bitten by ticks but have not developed the typical rash (16) .
